A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

NCT04215653 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Duodenal Ulcer，DU

Interventions

DRUG: Anaprazole Sodium
DRUG: Rabeprazole
DRUG: Rabeprazole Placebo
DRUG: Anaprazole Sodium Placebo

Sponsor

Sihuan Pharmaceutical Holdings Group Ltd.